🇺🇸 FDA
Patent

US 10166304

Antibody fragments for detecting cancer and methods of use

granted A61KA61K47/6855A61K47/6865

Quick answer

US patent 10166304 (Antibody fragments for detecting cancer and methods of use) held by Regents of the University of Minnesota expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K47/6855, A61K47/6865, A61K47/6869, A61K47/6929